These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25828419)

  • 1. Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013.
    Nishtala PS; Soo L
    Intern Med J; 2015 Jun; 45(6):624-9. PubMed ID: 25828419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.
    Tett SE; Sketris I; Cooke C; van Zanten SV; Barozzi N
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013.
    Ndukwe HC; Tordoff JM; Wang T; Nishtala PS
    Drugs Aging; 2014 Oct; 31(10):755-68. PubMed ID: 25204576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019.
    Nishtala PS; Chyou TY
    Drugs Aging; 2022 Aug; 39(8):657-669. PubMed ID: 35829958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
    Harris BN; West DS; Johnson J; Hong SH; Stowe CD
    J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic variation in psychotropic drug utilisation among older people in New Zealand.
    Ndukwe HC; Wang T; Tordoff JM; Croucher MJ; Nishtala PS
    Australas J Ageing; 2016 Dec; 35(4):242-248. PubMed ID: 26991493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board.
    Jarchow-Macdonald AA; Mangoni AA
    Geriatr Gerontol Int; 2013 Oct; 13(4):1002-9. PubMed ID: 23506515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
    Nishtala PS; Salahudeen MS
    Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection-a cross-sectional population-based study.
    Wallerstedt SM; Fastbom J; Linke J; Vitols S
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):9-16. PubMed ID: 27859947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database.
    Boucherie Q; Rouby F; Frankel D; Roll P; Micallef J
    Therapie; 2018 Oct; 73(5):385-388. PubMed ID: 29778306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013.
    Nishtala PS; Oh S; Kim D; Chun N; Binti Kamis SF; Kiu KC
    Drugs Real World Outcomes; 2015 Jun; 2(2):177-185. PubMed ID: 27747769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends for donepezil utilization among older people.
    Ndukwe HC; Nishtala PS
    Int Clin Psychopharmacol; 2016 May; 31(3):170-5. PubMed ID: 26626778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
    López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
    Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connections between nutritional status and proton pump inhibitor therapy in patients scheduled for cardiovascular rehabilitation after treatment for ischaemic and valvular heart disease.
    Boban M; Persic V; Petricevic M; Biocina B; Sipic T; Pehar-Pejcnovic V; Balen S; Zulj M; Vcev A
    Kardiol Pol; 2016; 74(5):461-468. PubMed ID: 26412474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.